Moneycontrol PRO
LAMF
LAMF

Biocon Limited

Jump to
  • Promoter Biocon sells 1.19% stake in Syngene International

    Biocon had a 54.45 percent stake in Syngene International as of September 30.

  • With refinancing done, focus will now be on debt reduction: Biocon Biologics CFO

    The funds raised will go a long way towards helping the company repay the debt it had taken on for the acquisition of Viatris Inc's biosimilars portfolio for over $3 billion.

  • Biocon share price surges after Morgan Stanley upgrades stock to 'outperform'

  • Corporate tax cut: Kiran Mazumdar Shaw hails Nirmala Sitharaman's move, days after criticism on economy

  • Biocon Initiates "EK Prayaas" Nationwide Awareness Program on Hepatitis C

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347